BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38616306)

  • 1. Development of a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma: Insights into Immune Cell Interactions and Drug Sensitivity.
    Wang P; Liu Y; Wei L; Wang J; Wang J; Du B
    Cancer Invest; 2024 Mar; 42(3):243-259. PubMed ID: 38616306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
    Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
    Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction and Validation of an Immune-Related Gene Prognostic Index for Esophageal Squamous Cell Carcinoma.
    Ji Q; Cai Y; Shrestha SM; Shen D; Zhao W; Shi R
    Biomed Res Int; 2021; 2021():7430315. PubMed ID: 34722771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma.
    Feng Z; Qu J; Liu X; Liang J; Li Y; Jiang J; Zhang H; Tian H
    Sci Rep; 2021 Aug; 11(1):16696. PubMed ID: 34404882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor infiltrating lymphocyte signature is associated with single nucleotide polymorphisms and predicts survival in esophageal squamous cell carcinoma patients.
    Suo C; Chen H; Binczyk F; Zhao R; Fan J; Yang X; Yuan Z; Kreil D; Łabaj P; Zhang T; Lu M; Jin L; Polańska J; Chen X; Ye W
    Aging (Albany NY); 2021 Apr; 13(7):10369-10386. PubMed ID: 33819921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a PLCE1‑regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinoma.
    Yang Z; Hui Y; Peng H; Zhang H; Li M; Song L; Li F; Cui X
    Oncol Rep; 2021 Mar; 45(3):857-868. PubMed ID: 33650665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.
    Zhao Y; Lu Q; Li C; Wang X; Jiang L; Huang L; Wang C; Chen H
    Cell Death Dis; 2019 May; 10(5):359. PubMed ID: 31043582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
    Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma.
    Ye Z; Fang J; Wang Z; Wang L; Li B; Liu T; Wang Y; Hua J; Wang F; Fu Z
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32662828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
    Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell Carcinoma.
    Zhang J; Wang H; Wu H; Qiang G
    Biomed Res Int; 2021; 2021():8635381. PubMed ID: 34616847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant MCM10 SUMOylation induces genomic instability mediated by a genetic variant associated with survival of esophageal squamous cell carcinoma.
    Tian J; Lu Z; Niu S; Zhang S; Ying P; Wang L; Zhang M; Cai Y; Dong T; Zhu Y; Zhong R; Wang Z; Chang J; Miao X
    Clin Transl Med; 2021 Jun; 11(6):e485. PubMed ID: 34185429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.